Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT)

CUSIP: 786700104

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
-3,720,986
Put/Call ratio
123%
SEC-reported price per share
$3.26
Number of holders
69
Value change
-$15,209,275
Number of buys
34
Open additional details 1 more signal available
Number of sells
30
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
72,470,421

Security key

786700104

Report period

Q1 2025

Institutions

69

Top holders

10

Ownership snapshot

Top reported holders of SGMT - Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Blue Owl Capital Holdings LP
Disclosed value leader
NEA Partners 13, Limited ...
Comparable rows
1/15
Latest evidence
31 Dec 2024
13F 13D/G 3/4/5 Lead comparable stake: 4.3% 14 rows are not safely comparable across share classes. 13D/G row: Blue Owl Capital Holdings LP Showing 1-6 of 15 holder rows.

Quick read

Blue Owl Capital Holdings LP leads the comparable SEC ownership view at 4.3%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Blue Owl Capital Holdings LP's linked filing trail.
Comparable ownership Top 1
Blue Owl Capital Holdings LP 4.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Blue Owl Capital Holdings LP
13F 13D/G
Company
4.3%
Reported 13D/G · 31 Dec 2024
$5,957,447
1,323,877 shares
— 31 Dec 2024
NEA Partners 13, Limited Partnership
3/4/5
10%+ Owner
—
denominator unverified
$12,301,128
3,000,275 shares
— 29 Jan 2024
NEW ENTERPRISE ASSOCIATES 13 LP
3/4/5
10%+ Owner
—
denominator unverified
$12,301,128
3,000,275 shares
— 29 Jan 2024
KPCB PBD Associates, LLC
3/4/5
10%+ Owner
—
denominator unverified
$7,787,848
1,899,475 shares
— 18 Jul 2023
Patrick J. Kerins
3/4/5
10%+ Owner
—
denominator unverified
$53,870
13,139 shares
— 29 Jan 2024
Forest Baskett
3/4/5
10%+ Owner
—
denominator unverified
$46,330
11,300 shares
— 29 Jan 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
69
Shares
13,776,513
Rows available
69
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2025 Across Filers

Q1 2025 holders
69
Q1 2025 holders
69
Holder diff
0
Investor Q1 2025 Shares Q1 2025 Shares Share Diff Share Chg % Q1 2025 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .